Carenostics
Back to news

Carenostics named Finalist for 2024 Enterprise Awards

PACT — the Philadelphia Alliance for Capital and Technologies — names Carenostics a finalist in the technology startup category at the 31st annual Enterprise Awards.

PHILADELPHIA, PA — Carenostics is pleased to announce its selection as a finalist for the 2024 Enterprise Awards, organized by PACT — Philadelphia Alliance for Capital and Technologies — with title sponsor Fairmount Partners and judging partner KPMG. This prestigious recognition underscores our commitment to innovation, excellence, and the impact we have made in AI in healthcare.

The Enterprise Awards, now in their 31st year, honor outstanding companies and individuals who have demonstrated exceptional achievements in technology, entrepreneurship, and leadership. Carenostics’ inclusion as a finalist in the technology startup category is a testament to our dedication to pushing the boundaries of AI in healthcare and making a positive impact on the business landscape.

“At Carenostics, we are driven by a passion for transforming healthcare through innovative AI solutions. Being named a finalist for the 2024 Enterprise Awards validates our dedication to addressing care gaps, improving patient outcomes, and driving efficiency in the healthcare sector.” — Kanishka Rao, COO and Co-Founder of Carenostics

Dean Miller, President and CEO of PACT, commented on Carenostics’ recognition, stating, “The Enterprise Awards celebrate the region’s most innovative companies, and Carenostics has rightfully earned its place among the finalists. Their commitment to excellence and innovation has contributed significantly to the advancement of AI in healthcare. We congratulate Carenostics on this well-deserved honor.”

The winners of the 2024 Enterprise Awards will be announced at an awards ceremony and networking reception event on May 21, 2024, at the Springfield Country Club, where industry leaders, entrepreneurs, and innovators will come together to celebrate the finalists’ achievements and the growth in Philadelphia.

About Carenostics

Carenostics revolutionizes patient care through the application of clinically-oriented artificial intelligence which identifies patients at risk for chronic diseases. The company’s cutting-edge platform seamlessly integrates into clinicians’ workflow, leading to faster, earlier diagnosis for a much greater number of patients. The result is improved patient outcomes and enhanced healthcare efficiency. Carenostics has received awards from Bio-IT World, the National Science Foundation, and the Digital Health Hub Foundation, and their work has been accepted for publication in NeurIPS and AMGA.

For media inquiries, please contact: Carenostics PR Team — inquiries@carenostics.com